Skip to content
healthcare.dev

Irbesartan and Hydrochlorothiazide

NDC 70518-1550, Irbesartan and Hydrochlorothiazide, tablet, from REMEDYREPACK INC..

Product NDC
70518-1550
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203072
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1550 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRBESARTAN300 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
70518-1550-07051815500090 TABLET in 1 BOTTLE, PLASTIC (70518-1550-0)
70518-1550-17051815500190 TABLET in 1 BOTTLE, PLASTIC (70518-1550-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/88aaa2a1-13be-4f56-ace6-66e899028007

Use it

Look up 70518-1550 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1550 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-1550. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.